{"id":{"repo_id":"uiuc","oai_identifier":"oai:www.ideals.illinois.edu:2142/84535"},"canonical_url":"https://search.dev.ndltd.org/etd/uiuc/oai:www.ideals.illinois.edu:2142/84535","repository":{"repo_id":"uiuc","name":"University of Illinois - Urbana-Champaign","base_url":"https://www.ideals.illinois.edu/oai-pmh"},"display":{"title":"The Determinants of Organizational Form in the Biotechnology Industry: An Integrative Organizational Economics Framework","abstract":"The inherently high level of uncertainty involved in alliances and the great discrepancy between the alliance partners' respective size and perspectives on the alliance were found to have an important impact on how client firms invested in R&D firms. Another important finding is that informal contracting mechanisms like reputation effects and repeated contracting seem to have complementary effects on the choice of organizational form, particularly in the magnitude of equity investment, rather than substituting for each other. Furthermore, the nature of equity investment in the pharmaceutical-biotechnology alliances in this sample suggests that investments are not made so much for equity participation, but as a financing method, and possibly as a signal of commitment. Lastly, the informal mechanisms seem to be byproducts of doing business, and thus seem to have little impact on the margin, but perhaps with the accumulation from many prior alliances and goodwill, may have some impact.","abstract_html":"The inherently high level of uncertainty involved in alliances and the great discrepancy between the alliance partners' respective size and perspectives on the alliance were found to have an important impact on how client firms invested in R&D firms. Another important finding is that informal contracting mechanisms like reputation effects and repeated contracting seem to have complementary effects on the choice of organizational form, particularly in the magnitude of equity investment, rather than substituting for each other. Furthermore, the nature of equity investment in the pharmaceutical-biotechnology alliances in this sample suggests that investments are not made so much for equity participation, but as a financing method, and possibly as a signal of commitment. Lastly, the informal mechanisms seem to be byproducts of doing business, and thus seem to have little impact on the margin, but perhaps with the accumulation from many prior alliances and goodwill, may have some impact.","abstract_has_math":false,"creators":["Kim, Jong Wook"],"institution":"University of Illinois at Urbana-Champaign","degree_name":"Ph.D.","degree_level":"Dissertation","degree_discipline":"Business Administration","degree_department":null,"school":null,"contributors":["Mahoney, Joseph T."],"advisors":[],"committee_chairs":[],"committee_members":[],"year":2004,"date_issued":"2004","date_published":"2004","updated_at":"2026-07-22T22:26:23Z","subjects":["Business Administration, Management"],"languages":["eng"],"rights":[],"rights_urls":[],"identifier_entries":[{"key":"dc:identifier","label":"Identifier","values":["(MiAaPQ)AAI3130954"],"render_values":[{"text":"(MiAaPQ)AAI3130954","href":null,"code":true}]}]},"links":{"outbound_url":"http://hdl.handle.net/2142/84535","outbound_label":"Handle","outbound_source":"dc:identifier"},"metadata_groups":[{"id":"people","label":"People","entries":[{"key":"dc:contributor","label":"Contributor","values":["Mahoney, Joseph T."]},{"key":"dc:creator","label":"Author","values":["Kim, Jong Wook"]}]},{"id":"academic_context","label":"Academic Context","entries":[{"key":"dc:date","label":"Dc Date","values":["2004","2015-09-25T22:21:31Z","10000-01-01"]},{"key":"dc:type","label":"Dc Type","values":["text"]},{"key":"thesis:degree_discipline","label":"Discipline","values":["Business Administration"]},{"key":"thesis:degree_level","label":"Degree Level","values":["Dissertation"]},{"key":"thesis:degree_name","label":"Degree Name","values":["Ph.D."]},{"key":"thesis:institution_name","label":"Thesis Institution Name","values":["University of Illinois at Urbana-Champaign"]}]},{"id":"subjects_keywords","label":"Subjects and Keywords","entries":[{"key":"dc:subject","label":"Dc Subject","values":["Business Administration, Management"]}]},{"id":"language_rights","label":"Language and Rights","entries":[{"key":"dc:language","label":"Dc Language","values":["eng"]}]},{"id":"identifiers","label":"Identifiers","entries":[{"key":"dc:identifier","label":"Identifier","values":["http://hdl.handle.net/2142/84535","(MiAaPQ)AAI3130954"]}]},{"id":"additional","label":"Additional Metadata","entries":[{"key":"dc:description","label":"Description","values":["The inherently high level of uncertainty involved in alliances and the great discrepancy between the alliance partners' respective size and perspectives on the alliance were found to have an important impact on how client firms invested in R&D firms. Another important finding is that informal contracting mechanisms like reputation effects and repeated contracting seem to have complementary effects on the choice of organizational form, particularly in the magnitude of equity investment, rather than substituting for each other. Furthermore, the nature of equity investment in the pharmaceutical-biotechnology alliances in this sample suggests that investments are not made so much for equity participation, but as a financing method, and possibly as a signal of commitment. Lastly, the informal mechanisms seem to be byproducts of doing business, and thus seem to have little impact on the margin, but perhaps with the accumulation from many prior alliances and goodwill, may have some impact.","Made available in DSpace on 2015-09-25T22:21:31Z (GMT). No. of bitstreams: 2 license.txt: 4848 bytes, checksum: 96035ab3f5e1c23cc7138a224ce498bd (MD5) 3130954.pdf: 7304563 bytes, checksum: 12aee8a9d12a41224d423f73cfa0a5af (MD5) Previous issue date: 2004","Embargo set by: Seth Robbins for item 85816 Lift date: Forever Reason: Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","U of I Only","133 p.","Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2004."]},{"key":"dc:title","label":"Title","values":["The Determinants of Organizational Form in the Biotechnology Industry: An Integrative Organizational Economics Framework"]}]}],"canonical_facts":{"dc:contributor":["Mahoney, Joseph T."],"dc:creator":["Kim, Jong Wook"],"dc:date":["2004","2015-09-25T22:21:31Z","10000-01-01"],"dc:description":["The inherently high level of uncertainty involved in alliances and the great discrepancy between the alliance partners' respective size and perspectives on the alliance were found to have an important impact on how client firms invested in R&D firms. Another important finding is that informal contracting mechanisms like reputation effects and repeated contracting seem to have complementary effects on the choice of organizational form, particularly in the magnitude of equity investment, rather than substituting for each other. Furthermore, the nature of equity investment in the pharmaceutical-biotechnology alliances in this sample suggests that investments are not made so much for equity participation, but as a financing method, and possibly as a signal of commitment. Lastly, the informal mechanisms seem to be byproducts of doing business, and thus seem to have little impact on the margin, but perhaps with the accumulation from many prior alliances and goodwill, may have some impact.","Made available in DSpace on 2015-09-25T22:21:31Z (GMT). No. of bitstreams: 2 license.txt: 4848 bytes, checksum: 96035ab3f5e1c23cc7138a224ce498bd (MD5) 3130954.pdf: 7304563 bytes, checksum: 12aee8a9d12a41224d423f73cfa0a5af (MD5) Previous issue date: 2004","Embargo set by: Seth Robbins for item 85816 Lift date: Forever Reason: Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","Restricted to the U of I community idenfinitely during batch ingest of legacy ETDs","U of I Only","133 p.","Thesis (Ph.D.)--University of Illinois at Urbana-Champaign, 2004."],"dc:identifier":["http://hdl.handle.net/2142/84535","(MiAaPQ)AAI3130954"],"dc:language":["eng"],"dc:subject":["Business Administration, Management"],"dc:title":["The Determinants of Organizational Form in the Biotechnology Industry: An Integrative Organizational Economics Framework"],"dc:type":["text"],"thesis:degree_discipline":["Business Administration"],"thesis:degree_level":["Dissertation"],"thesis:degree_name":["Ph.D."],"thesis:institution_name":["University of Illinois at Urbana-Champaign"]},"updated_at":"2026-07-22T22:26:23Z"}